INBX Stock Analysis: Buy, Sell, or Hold?
INBX - Inhibrx Biosciences, Inc. Common Stock
$59.88
1.49 (2.55%)
▲
5d:
-7.35%
30d:
-19.22%
90d:
-25.35%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 13, 2026
Smart Money Accumulation
INBX is down 4.2% this week, but smart money is accumulating calls. Top strike: $75 2026-05-15 with 140 OI. Call ratio: 100% View Scanner →
Strength: 7.0/10
Get Alerted When INBX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: INBX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: INBX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: INBX is currently trading at $59.88, which is considered oversold relative to its 30-day fair value range of $64.41 to $76.29.
Technical Outlook: Technically, INBX is in a downtrend. Immediate support is located at $57.30, while resistance sits at $72.70.
Market Sentiment: INBX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (24th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $12.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, INBX is in a downtrend. Immediate support is located at $57.30, while resistance sits at $72.70.
Market Sentiment: INBX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (24th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $12.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$64.41 -
$76.29
Company Quality Score
53/100
(HOLD)
Options IV Signal
24th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
58.3%
Protect Your Profits
Holding INBX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 24th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 80.0% above Wall St target ($12.00)
- CAUTION: 5-day price weakness (-7.3%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$64.41 -
$76.29
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$7.60
(12.7%)
Support & Resistance Levels
Support Level
$57.30
Resistance Level
$72.70
Current Trend
Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-21.46
Wall Street Target
$12.00
(-80.0%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: March 31, 2026 5:06 AM ET
Data refreshes hourly during market hours. Next update: 6:06 AM
Data refreshes hourly during market hours. Next update: 6:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INBX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Global Investors Lp Viki…
SELL
350000 shares
2025-10-07
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 63 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$873 | 56 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 59 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 60 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$224 | 57 HOLD |
Advanced INBX Option Strategies
Professional options setups generated by AI based on today's INBX price and gamma walls.
